517 related articles for article (PubMed ID: 19048615)
21. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
[TBL] [Abstract][Full Text] [Related]
22. Effects of dissolved oxygen on hybridoma cell growth, metabolism, and antibody production kinetics in continuous culture.
Ozturk SS; Palsson BO
Biotechnol Prog; 1990; 6(6):437-46. PubMed ID: 1366834
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
[TBL] [Abstract][Full Text] [Related]
24. Genome-scale analysis of Saccharomyces cerevisiae metabolism and ethanol production in fed-batch culture.
Hjersted JL; Henson MA; Mahadevan R
Biotechnol Bioeng; 2007 Aug; 97(5):1190-204. PubMed ID: 17243146
[TBL] [Abstract][Full Text] [Related]
25. [Monoclonal antibody metabolism during the growth of hybridoma cells].
Morenkov OS; Mantsygin IuA; Lezhenev EI
Tsitologiia; 1988 May; 30(5):611-5. PubMed ID: 2972097
[TBL] [Abstract][Full Text] [Related]
26. Effect of glucose on the cultivation of mammalian cells.
Hu WS; Dodge TC; Frame KK; Himes VB
Dev Biol Stand; 1987; 66():279-90. PubMed ID: 3582758
[TBL] [Abstract][Full Text] [Related]
27. Adaptive, model-based control by the Open-Loop-Feedback-Optimal (OLFO) controller for the effective fed-batch cultivation of hybridoma cells.
Frahm B; Lane P; Atzert H; Munack A; Hoffmann M; Hass VC; Pörtner R
Biotechnol Prog; 2002; 18(5):1095-103. PubMed ID: 12363363
[TBL] [Abstract][Full Text] [Related]
28. Analysis of nutritional factors and physical conditions affecting growth and monoclonal antibody production of the hybridoma KB-26.5 cell line.
Sanfeliu A; Cairo JJ; Casas C; Sola C; Godia F
Biotechnol Prog; 1996; 12(2):209-16. PubMed ID: 8857191
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody production using a new supermacroporous cryogel bioreactor.
Nilsang S; Nandakumar KS; Galaev IY; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
Biotechnol Prog; 2007; 23(4):932-9. PubMed ID: 17590012
[TBL] [Abstract][Full Text] [Related]
30. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
Cherlet M; Marc A
Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
[TBL] [Abstract][Full Text] [Related]
31. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
[TBL] [Abstract][Full Text] [Related]
32. Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media.
Sidorenko Y; Wahl A; Dauner M; Genzel Y; Reichl U
Biotechnol Prog; 2008; 24(2):311-20. PubMed ID: 18215054
[TBL] [Abstract][Full Text] [Related]
33. Characterizing Escherichia coli DH5alpha growth and metabolism in a complex medium using genome-scale flux analysis.
Selvarasu S; Ow DS; Lee SY; Lee MM; Oh SK; Karimi IA; Lee DY
Biotechnol Bioeng; 2009 Feb; 102(3):923-34. PubMed ID: 18853410
[TBL] [Abstract][Full Text] [Related]
34. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
Lee YY; Yap MG; Hu WS; Wong KT
Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
[TBL] [Abstract][Full Text] [Related]
35. Optimization and robustness analysis of hybridoma cell fed-batch cultures using the overflow metabolism model.
Amribt Z; Dewasme L; Vande Wouwer A; Bogaerts P
Bioprocess Biosyst Eng; 2014 Aug; 37(8):1637-52. PubMed ID: 24519722
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody process development using medium concentrates.
Bibila TA; Ranucci CS; Glazomitsky K; Buckland BC; Aunins JG
Biotechnol Prog; 1994; 10(1):87-96. PubMed ID: 7764531
[TBL] [Abstract][Full Text] [Related]
37. Dynamic optimization of hybridoma growth in a fed-batch bioreactor.
Dhir S; Morrow KJ; Rhinehart RR; Wiesner T
Biotechnol Bioeng; 2000 Jan; 67(2):197-205. PubMed ID: 10592517
[TBL] [Abstract][Full Text] [Related]
38. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
39. Strategies for fed-batch cultivation of t-PA producing CHO cells: substitution of glucose and glutamine and rational design of culture medium.
Altamirano C; Paredes C; Illanes A; Cairó JJ; Gòdia F
J Biotechnol; 2004 May; 110(2):171-9. PubMed ID: 15121336
[TBL] [Abstract][Full Text] [Related]
40. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
